Bots, editor, reviewer, Administrators
13,941
edits
Feed:All articles/Pretty: Difference between revisions
Jump to navigation
Jump to search
no edit summary
No edit summary |
No edit summary |
||
| Line 4,089: | Line 4,089: | ||
}, | }, | ||
{ | { | ||
"timestamp" : "2018-04- | "timestamp" : "2018-04-26T20:18:28Z", | ||
"briefDesignDescription" : "Fondaparinux vs. enoxaparin in NSTE-ACS", | "briefDesignDescription" : "Fondaparinux vs. enoxaparin in NSTE-ACS", | ||
"fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa055443", | "fulltexturl" : "http://www.nejm.org/doi/full/10.1056/NEJMoa055443", | ||
| Line 4,097: | Line 4,097: | ||
"citation" : "Yusuf S, <i>et al</i>. \"Comparison of fondaparinux and enoxaparin in acute coronary syndromes\". <i>The New England Journal of Medicine</i>. 2006. 354(14):1464-1476.", | "citation" : "Yusuf S, <i>et al</i>. \"Comparison of fondaparinux and enoxaparin in acute coronary syndromes\". <i>The New England Journal of Medicine</i>. 2006. 354(14):1464-1476.", | ||
"subspecialties" : "Cardiology", | "subspecialties" : "Cardiology", | ||
"expansion" : "", | "expansion" : "Fifth Organization to Assess Strategies in Acute Ischemic Syndromes", | ||
"statusUsableDate" : " | "statusUsableDate" : "2018-04-27", | ||
"briefResultsDescription" : "Fondaparinux is non-inferior to enoxaparin in NSTE-ACS", | "briefResultsDescription" : "Fondaparinux is non-inferior to enoxaparin in NSTE-ACS", | ||
"published" : "2006-04-06", | "published" : "2006-04-06", | ||